This training will provide a comprehensive review of privacy and confidentiality laws relevant to opioid treatment providers. The session will cover federal and Nevada regulations, including HIPAA and 42 CFR Part 2, with a focus on practical applications and compliance challenges. The presentation will also explore emerging issues related to artificial intelligence and telehealth in opioid treatment settings. Participants will gain a clear understanding of confidentiality requirements, reporting obligations, and best practices for protecting patient privacy.

Presented by: Mark Disselkoen, MSSW, LCSW, LCADC

Mark Disselkoen, is Senior Project Manager at the Center for the Application of Substance Abuse Technologies (CASAT) at the University of Nevada, Reno since 2003. He is an LCSW and LCADC and has worked in the field of substance use and mental health treatment for over 30 years. He oversees the CCBHC project and certification and training/technical assistance contracts in Nevada and provides numerous trainings in the field of substance use and mental health treatment.

Continuing Education Units: 3 CEUs

This training is approved for continuing education by the boards listed here.

Funding for this activity was made possible in whole or in part by the Nevada Department of Health and Human Services (DHHS) Director’s Office through the Fund for a Resilient Nevada, established in Nevada Revised Statutes 433.712 through 433.744. The opinions, findings, conclusions, and recommendations expressed in our courses are those of the author(s) and do not necessarily represent the official views of the Nevada Opioid Center of Excellence or its funders.